Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Circulating miR-122 and miR-192 as Specific and Sensitive Biomarkers for Drug-Induced Liver Injury with Acetaminophen in Rats

Pouria Jarsiah 1 , Mohammad Karami 1 , Anahita Nosrati 2 , Ahad Alizadeh 3 and Mohammad Bagher Hashemi-Soteh 4 , *
Authors Information
1 Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
2 Laboratory of Pathobiology, Imam Khomeini Hospital, Sari, Iran
3 Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
4 Immunogenetic Research Center, Molecular and Cell biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: May 31, 2019, 14 (2); e65678
  • Published Online: December 16, 2018
  • Article Type: Research Article
  • Received: December 28, 2017
  • Revised: April 15, 2018
  • Accepted: May 14, 2018
  • DOI: 10.5812/jjnpp.65678

To Cite: Jarsiah P, Karami M, Nosrati A, Alizadeh A, Hashemi-Soteh M B. Circulating miR-122 and miR-192 as Specific and Sensitive Biomarkers for Drug-Induced Liver Injury with Acetaminophen in Rats, Jundishapur J Nat Pharm Prod. 2019 ; 14(2):e65678. doi: 10.5812/jjnpp.65678.

Copyright © 2018, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Tamai S, Iguchi T, Niino N, Mikamoto K, Sakurai K, Sayama A, et al. A monkey model of acetaminophen-induced hepatotoxicity; phenotypic similarity to human. J Toxicol Sci. 2017;42(1):73-84. doi: 10.2131/jts.42.73. [PubMed: 28070111].
  • 2. Fontana RJ. Acute liver failure due to drugs. Semin Liver Dis. 2008;28(2):175-87. doi: 10.1055/s-2008-1073117. [PubMed: 18452117].
  • 3. Davis DC, Potter WZ, Jollow DJ, Mitchell JR. Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci. 1974;14(11):2099-109. doi: 10.1016/0024-3205(74)90092-7. [PubMed: 4847802].
  • 4. Ozer JS, Chetty R, Kenna G, Palandra J, Zhang Y, Lanevschi A, et al. Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury. Regul Toxicol Pharmacol. 2010;56(3):237-46. doi: 10.1016/j.yrtph.2009.11.001. [PubMed: 19903504].
  • 5. Thulin P, Hornby RJ, Auli M, Nordahl G, Antoine DJ, Starkey Lewis P, et al. A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat. Biomarkers. 2017;22(5):461-9. doi: 10.1080/1354750X.2016.1269131. [PubMed: 27978773].
  • 6. Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 2011;54(5):1767-76. doi: 10.1002/hep.24538. [PubMed: 22045675].
  • 7. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513-8. doi: 10.1073/pnas.0804549105. [PubMed: 18663219]. [PubMed Central: PMC2492472].
  • 8. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, et al. A robust methodology to study urine microRNA as tumor marker: MicroRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol. 2010;28(6):655-61. doi: 10.1016/j.urolonc.2009.01.027. [PubMed: 19375957].
  • 9. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 2009;28(40):3526-36. doi: 10.1038/onc.2009.211. [PubMed: 19617899]. [PubMed Central: PMC3492882].
  • 10. Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, et al. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One. 2013;8(1). e54612. doi: 10.1371/journal.pone.0054612. [PubMed: 23372743]. [PubMed Central: PMC3555785].
  • 11. Ben-Shachar R, Chen Y, Luo S, Hartman C, Reed M, Nijhout HF. The biochemistry of acetaminophen hepatotoxicity and rescue: A mathematical model. Theor Biol Med Model. 2012;9:55. doi: 10.1186/1742-4682-9-55. [PubMed: 23249634]. [PubMed Central: PMC3576299].
  • 12. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012;13(6):e249-58. doi: 10.1016/S1470-2045(12)70073-6. [PubMed: 22652233].
  • 13. Yamaura Y, Nakajima M, Takagi S, Fukami T, Tsuneyama K, Yokoi T. Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. PLoS One. 2012;7(2). e30250. doi: 10.1371/journal.pone.0030250. [PubMed: 22363424]. [PubMed Central: PMC3281829].
  • 14. Roderburg C, Benz F, Vargas Cardenas D, Koch A, Janssen J, Vucur M, et al. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int. 2015;35(4):1172-84. doi: 10.1111/liv.12627. [PubMed: 25039534].
  • 15. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 2011;80(2):193-208. doi: 10.1016/j.critrevonc.2010.11.004. [PubMed: 21145252].
  • 16. Hornby RJ, Starkey Lewis P, Dear J, Goldring C, Park BK. MicroRNAs as potential circulating biomarkers of drug-induced liver injury: Key current and future issues for translation to humans. Expert Rev Clin Pharmacol. 2014;7(3):349-62. doi: 10.1586/17512433.2014.904201. [PubMed: 24694030].
  • 17. Jarsiah P, Nosrati A, Alizadeh A, Hashemi-Soteh SMB. Hepatotoxicity and ALT/AST enzymes activities change in therapeutic and toxic doses consumption of acetaminophen in rats. Int Biolog Biomed J. 2017;3(3):119-24.
  • 18. Cheung L, Gustavsson C, Norstedt G, Tollet-Egnell P. Sex-different and growth hormone-regulated expression of microRNA in rat liver. BMC Mol Biol. 2009;10:13. doi: 10.1186/1471-2199-10-13. [PubMed: 19236699]. [PubMed Central: PMC2654566].
  • 19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8. doi: 10.1006/meth.2001.1262. [PubMed: 11846609].
  • 20. Rangnekar AS, Fontana RJ. An update on drug induced liver injury. Minerva Gastroenterol Dietol. 2011;57(2):213-29. [PubMed: 21587150].
  • 21. Antoine DJ, Mercer AE, Williams DP, Park BK. Mechanism-based bioanalysis and biomarkers for hepatic chemical stress. Xenobiotica. 2009;39(8):565-77. doi: 10.1080/00498250903046993. [PubMed: 19621999].
  • 22. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008;245(3):194-205. doi: 10.1016/j.tox.2007.11.021. [PubMed: 18291570].
  • 23. Starckx S, Batheja A, Verheyen GR, Jonghe SD, Steemans K, Dijck BV, et al. Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats. Toxicol Pathol. 2013;41(5):795-804. doi: 10.1177/0192623312464436. [PubMed: 23143187].
  • 24. Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777-87. doi: 10.1002/hep.26294. [PubMed: 23390034]. [PubMed Central: PMC3842113].
  • 25. Wu C, Zhang J, Cao X, Yang Q, Xia D. Effect of Mir-122 on human cholangiocarcinoma proliferation, invasion, and apoptosis through P53 expression. Med Sci Monit. 2016;22:2685-90. doi: 10.12659/MSM.896404. [PubMed: 27472451]. [PubMed Central: PMC4976756].
  • 26. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106(11):4402-7. doi: 10.1073/pnas.0813371106. [PubMed: 19246379]. [PubMed Central: PMC2657429].
  • 27. Salamin O, Jaggi L, Baume N, Robinson N, Saugy M, Leuenberger N. Circulating microRNA-122 as potential biomarker for detection of testosterone abuse. PLoS One. 2016;11(5). e0155248. doi: 10.1371/journal.pone.0155248. [PubMed: 27171140]. [PubMed Central: PMC4865044].
  • 28. Sharapova T, Devanarayan V, LeRoy B, Liguori MJ, Blomme E, Buck W, et al. Evaluation of miR-122 as a serum biomarker for hepatotoxicity in investigative rat toxicology studies. Vet Pathol. 2016;53(1):211-21. doi: 10.1177/0300985815591076. [PubMed: 26123229].
  • 29. Chang J, Guo JT, Jiang D, Guo H, Taylor JM, Block TM. Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol. 2008;82(16):8215-23. doi: 10.1128/JVI.02575-07. [PubMed: 18550664]. [PubMed Central: PMC2519557].
  • 30. Zhang X, Zhang Z, Dai F, Shi B, Chen L, Zhang X, et al. Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C. PLoS One. 2014;9(3). e92112. doi: 10.1371/journal.pone.0092112. [PubMed: 24643113]. [PubMed Central: PMC3958472].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments